

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-serine transport (GO:0015825) | 6.72389910 |
| 2 | serine transport (GO:0032329) | 6.20570786 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.50018144 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.60005227 |
| 5 | alanine transport (GO:0032328) | 4.58819139 |
| 6 | auditory behavior (GO:0031223) | 4.50735359 |
| 7 | protein complex biogenesis (GO:0070271) | 4.37906545 |
| 8 | protein-cofactor linkage (GO:0018065) | 4.33588172 |
| 9 | proteasome assembly (GO:0043248) | 4.20067659 |
| 10 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.19576377 |
| 11 | NADH dehydrogenase complex assembly (GO:0010257) | 4.19576377 |
| 12 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.19576377 |
| 13 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.13018904 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.06879506 |
| 15 | cullin deneddylation (GO:0010388) | 4.03616439 |
| 16 | positive regulation of B cell differentiation (GO:0045579) | 4.03562975 |
| 17 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.03333768 |
| 18 | protein deneddylation (GO:0000338) | 4.01719425 |
| 19 | natural killer cell differentiation (GO:0001779) | 3.99007022 |
| 20 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.96621460 |
| 21 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.93557472 |
| 22 | response to interleukin-15 (GO:0070672) | 3.92724090 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91442400 |
| 24 | positive regulation of histone deacetylation (GO:0031065) | 3.87137994 |
| 25 | regulation of fever generation (GO:0031620) | 3.80586723 |
| 26 | DNA double-strand break processing (GO:0000729) | 3.79878208 |
| 27 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.78898711 |
| 28 | ATP synthesis coupled proton transport (GO:0015986) | 3.77057492 |
| 29 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.77057492 |
| 30 | respiratory chain complex IV assembly (GO:0008535) | 3.71185256 |
| 31 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.69286938 |
| 32 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.69286938 |
| 33 | amino acid import (GO:0043090) | 3.69251264 |
| 34 | positive thymic T cell selection (GO:0045059) | 3.66170146 |
| 35 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 3.66087696 |
| 36 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.65754623 |
| 37 | positive regulation of mitochondrial fission (GO:0090141) | 3.64749517 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 3.64289340 |
| 39 | positive regulation of granulocyte differentiation (GO:0030854) | 3.63335613 |
| 40 | respiratory electron transport chain (GO:0022904) | 3.62292239 |
| 41 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.61197423 |
| 42 | mechanosensory behavior (GO:0007638) | 3.60867867 |
| 43 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.59572679 |
| 44 | sodium ion export (GO:0071436) | 3.58905079 |
| 45 | electron transport chain (GO:0022900) | 3.57311580 |
| 46 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.54963589 |
| 47 | C4-dicarboxylate transport (GO:0015740) | 3.53060324 |
| 48 | regulation of B cell differentiation (GO:0045577) | 3.51690863 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.50251973 |
| 50 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.47095860 |
| 51 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.39616523 |
| 52 | negative thymic T cell selection (GO:0045060) | 3.38981292 |
| 53 | negative T cell selection (GO:0043383) | 3.38945138 |
| 54 | DNA deamination (GO:0045006) | 3.38829574 |
| 55 | regulation of heat generation (GO:0031650) | 3.37416351 |
| 56 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.36915507 |
| 57 | regulation of histone H3-K27 methylation (GO:0061085) | 3.36205307 |
| 58 | histone H2A acetylation (GO:0043968) | 3.35663816 |
| 59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.34747239 |
| 60 | L-amino acid import (GO:0043092) | 3.34639972 |
| 61 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.34067443 |
| 62 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.33958429 |
| 63 | chaperone-mediated protein transport (GO:0072321) | 3.32044220 |
| 64 | neutral amino acid transport (GO:0015804) | 3.25911885 |
| 65 | platelet dense granule organization (GO:0060155) | 3.25464997 |
| 66 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.24540178 |
| 67 | cytochrome complex assembly (GO:0017004) | 3.23420104 |
| 68 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.21074263 |
| 69 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.19803019 |
| 70 | negative regulation of ligase activity (GO:0051352) | 3.19803019 |
| 71 | intracellular protein transmembrane import (GO:0044743) | 3.15646966 |
| 72 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.14510612 |
| 73 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.14510612 |
| 74 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.14510612 |
| 75 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.14459193 |
| 76 | protein neddylation (GO:0045116) | 3.12574268 |
| 77 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.12082908 |
| 78 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.12082908 |
| 79 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.11507642 |
| 80 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.08409201 |
| 81 | protein kinase C signaling (GO:0070528) | 3.07753445 |
| 82 | neurotransmitter uptake (GO:0001504) | 3.07429402 |
| 83 | response to auditory stimulus (GO:0010996) | 3.05656390 |
| 84 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.05617433 |
| 85 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.05372593 |
| 86 | negative regulation of stress fiber assembly (GO:0051497) | 3.04543062 |
| 87 | GMP metabolic process (GO:0046037) | 3.01760292 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 3.01379900 |
| 89 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.98027974 |
| 90 | regulation of mitochondrial translation (GO:0070129) | 2.97150851 |
| 91 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.97117451 |
| 92 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.97117451 |
| 93 | anterograde synaptic vesicle transport (GO:0048490) | 2.96993792 |
| 94 | cellular potassium ion homeostasis (GO:0030007) | 2.96881483 |
| 95 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.96773160 |
| 96 | ribonucleoprotein complex disassembly (GO:0032988) | 2.95777951 |
| 97 | organelle disassembly (GO:1903008) | 2.94482904 |
| 98 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.92495847 |
| 99 | gamma-aminobutyric acid transport (GO:0015812) | 2.91825907 |
| 100 | intraciliary transport (GO:0042073) | 2.90489701 |
| 101 | purine-containing compound salvage (GO:0043101) | 2.89826712 |
| 102 | DNA unwinding involved in DNA replication (GO:0006268) | 2.89651160 |
| 103 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.89152806 |
| 104 | positive regulation of ligase activity (GO:0051351) | 2.88086047 |
| 105 | regulation of penile erection (GO:0060405) | 2.86516151 |
| 106 | ncRNA 3-end processing (GO:0043628) | 2.85579109 |
| 107 | megakaryocyte development (GO:0035855) | 2.84523173 |
| 108 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.84430752 |
| 109 | pseudouridine synthesis (GO:0001522) | 2.84351952 |
| 110 | response to host defenses (GO:0052200) | 2.83949948 |
| 111 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83949948 |
| 112 | response to host (GO:0075136) | 2.83949948 |
| 113 | startle response (GO:0001964) | 2.83361033 |
| 114 | mannosylation (GO:0097502) | 2.83213169 |
| 115 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.83026652 |
| 116 | positive regulation of RNA splicing (GO:0033120) | 2.81677831 |
| 117 | heparin metabolic process (GO:0030202) | 2.81601042 |
| 118 | heparin biosynthetic process (GO:0030210) | 2.81601042 |
| 119 | Peyers patch development (GO:0048541) | 2.80947561 |
| 120 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.80947561 |
| 121 | maturation of 5.8S rRNA (GO:0000460) | 2.80517759 |
| 122 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.79895953 |
| 123 | positive T cell selection (GO:0043368) | 2.79726308 |
| 124 | positive regulation by symbiont of host defense response (GO:0052509) | 2.79364016 |
| 125 | modulation by symbiont of host defense response (GO:0052031) | 2.79364016 |
| 126 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.79364016 |
| 127 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.79364016 |
| 128 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.79364016 |
| 129 | modulation by symbiont of host immune response (GO:0052553) | 2.79364016 |
| 130 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.79092630 |
| 131 | positive regulation of protein deacetylation (GO:0090312) | 2.78782217 |
| 132 | protein import into peroxisome matrix (GO:0016558) | 2.78768841 |
| 133 | regulation of response to interferon-gamma (GO:0060330) | 2.77604192 |
| 134 | DNA damage response, detection of DNA damage (GO:0042769) | 2.75806755 |
| 135 | inner mitochondrial membrane organization (GO:0007007) | 2.75547823 |
| 136 | * regulation of sister chromatid cohesion (GO:0007063) | 2.75009864 |
| 137 | secretory granule organization (GO:0033363) | 2.74282557 |
| 138 | T cell selection (GO:0045058) | 2.72451312 |
| 139 | cellular response to interferon-beta (GO:0035458) | 2.72412872 |
| 140 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70509887 |
| 141 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.70509887 |
| 142 | cellular response to zinc ion (GO:0071294) | 2.68730493 |
| 143 | inositol phosphate catabolic process (GO:0071545) | 2.68484376 |
| 144 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.68422562 |
| 145 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.68413160 |
| 146 | negative regulation of cell killing (GO:0031342) | 2.68413160 |
| 147 | mannose metabolic process (GO:0006013) | 2.67844105 |
| 148 | positive regulation of interferon-alpha production (GO:0032727) | 2.67095364 |
| 149 | interferon-gamma production (GO:0032609) | 2.66916681 |
| 150 | cellular response to interleukin-15 (GO:0071350) | 2.66711214 |
| 151 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.66286266 |
| 152 | protein prenylation (GO:0018342) | 2.64383976 |
| 153 | prenylation (GO:0097354) | 2.64383976 |
| 154 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.61702492 |
| 155 | ubiquinone biosynthetic process (GO:0006744) | 2.60909440 |
| 156 | thymic T cell selection (GO:0045061) | 2.60460613 |
| 157 | tRNA processing (GO:0008033) | 2.60400418 |
| 158 | acidic amino acid transport (GO:0015800) | 2.60072933 |
| 159 | replication fork processing (GO:0031297) | 2.59967401 |
| 160 | mitotic sister chromatid cohesion (GO:0007064) | 2.59838689 |
| 161 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.58694895 |
| 162 | branched-chain amino acid catabolic process (GO:0009083) | 2.58068347 |
| 163 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.57845150 |
| 164 | inositol phosphate dephosphorylation (GO:0046855) | 2.57845150 |
| 165 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.57192455 |
| 166 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.57192455 |
| 167 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.56612636 |
| 168 | protein K11-linked deubiquitination (GO:0035871) | 2.56016696 |
| 169 | positive regulation of lamellipodium organization (GO:1902745) | 2.55949238 |
| 170 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.55216330 |
| 171 | centriole replication (GO:0007099) | 2.55208576 |
| 172 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.54840897 |
| 173 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.54840897 |
| 174 | leukocyte aggregation (GO:0070486) | 2.54505077 |
| 175 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.54219992 |
| 176 | hydrogen ion transmembrane transport (GO:1902600) | 2.54014863 |
| 177 | T cell homeostasis (GO:0043029) | 2.53166345 |
| 178 | natural killer cell activation (GO:0030101) | 2.52710158 |
| 179 | tRNA metabolic process (GO:0006399) | 2.52707957 |
| 180 | energy homeostasis (GO:0097009) | 2.52616512 |
| 181 | pentose-phosphate shunt (GO:0006098) | 2.52020423 |
| 182 | detection of chemical stimulus involved in sensory perception of smell (GO:0050911) | 2.51853972 |
| 183 | regulation of interferon-alpha production (GO:0032647) | 2.51324885 |
| 184 | cellular response to virus (GO:0098586) | 2.50311205 |
| 185 | sequestering of actin monomers (GO:0042989) | 2.48622339 |
| 186 | protein K11-linked ubiquitination (GO:0070979) | 2.48036500 |
| 187 | protein targeting to mitochondrion (GO:0006626) | 2.47417967 |
| 188 | innervation (GO:0060384) | 2.47134233 |
| 189 | base-excision repair, AP site formation (GO:0006285) | 2.47049355 |
| 190 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.46899301 |
| 191 | amino acid salvage (GO:0043102) | 2.46797838 |
| 192 | L-methionine salvage (GO:0071267) | 2.46797838 |
| 193 | L-methionine biosynthetic process (GO:0071265) | 2.46797838 |
| 194 | regulation of ligase activity (GO:0051340) | 2.46174454 |
| 195 | regulation of cellular amine metabolic process (GO:0033238) | 2.45964519 |
| 196 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.45578974 |
| 197 | phasic smooth muscle contraction (GO:0014821) | 2.45110400 |
| 198 | intracellular protein transmembrane transport (GO:0065002) | 2.43937469 |
| 199 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.43524723 |
| 200 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.43524723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.53924450 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.57982112 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.44766484 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.00378347 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.96031914 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.94088442 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.83140743 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.68576945 |
| 9 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.55727487 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.53156667 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.36426291 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.33503255 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 3.33216843 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.25832505 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.07224711 |
| 16 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.06548989 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.92515462 |
| 18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.80823328 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.68913866 |
| 20 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.67607985 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.66265248 |
| 22 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.65877786 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.60074526 |
| 24 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.58608929 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58594623 |
| 26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.54238197 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 2.53182177 |
| 28 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.46239626 |
| 29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.42254932 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 2.41182232 |
| 31 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.40674006 |
| 32 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.31352317 |
| 33 | VDR_22108803_ChIP-Seq_LS180_Human | 2.27770573 |
| 34 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.27532188 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 2.25637524 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 2.15543032 |
| 37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.14329635 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.13492069 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.11402795 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.08387047 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.07083405 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 2.06887735 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01377330 |
| 44 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.98646217 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91887936 |
| 46 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.91204104 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.90585631 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90315242 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.90275934 |
| 50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.89390399 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88688124 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.88289587 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87892351 |
| 54 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86742550 |
| 55 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.86219742 |
| 56 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85723461 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.84952826 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.83514042 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79972321 |
| 60 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78173207 |
| 61 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77406496 |
| 62 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77000777 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.76363219 |
| 64 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.74993496 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74476079 |
| 66 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74091634 |
| 67 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.73331012 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72773012 |
| 69 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71697883 |
| 70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.71643827 |
| 71 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.70615052 |
| 72 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.68184612 |
| 73 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.66716665 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.66536573 |
| 75 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66465310 |
| 76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.65985668 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.65791882 |
| 78 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.64003525 |
| 79 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.63579726 |
| 80 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63265622 |
| 81 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.63212191 |
| 82 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.58422479 |
| 83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.56161659 |
| 84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56122104 |
| 85 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53876685 |
| 86 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.53815793 |
| 87 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52593919 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.51436463 |
| 89 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.46898510 |
| 90 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40990031 |
| 91 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.40365584 |
| 92 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.40156306 |
| 93 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.36984782 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35834304 |
| 95 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.31487491 |
| 96 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30819522 |
| 97 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.28295221 |
| 98 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.24284105 |
| 99 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.22968257 |
| 100 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.22454622 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20270424 |
| 102 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19273371 |
| 103 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.18787764 |
| 104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18511345 |
| 105 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16812127 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16719983 |
| 107 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.16074104 |
| 108 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14721425 |
| 109 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14181147 |
| 110 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.13450400 |
| 111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.12667278 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12243063 |
| 113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.11747433 |
| 114 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11451934 |
| 115 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11425380 |
| 116 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11400495 |
| 117 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11400495 |
| 118 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.10034062 |
| 119 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.10034062 |
| 120 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.09359166 |
| 121 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.09065526 |
| 122 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.09065526 |
| 123 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.08811327 |
| 124 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07175633 |
| 125 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.06667811 |
| 126 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06573418 |
| 127 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05852352 |
| 128 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05648170 |
| 129 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04534895 |
| 130 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.03253817 |
| 131 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.02941072 |
| 132 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.02500896 |
| 133 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.01970154 |
| 134 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01795930 |
| 135 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00405180 |
| 136 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99537853 |
| 137 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99207537 |
| 138 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99098813 |
| 139 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97627171 |
| 140 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97288571 |
| 141 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97267496 |
| 142 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97214321 |
| 143 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.96603846 |
| 144 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96244532 |
| 145 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95883240 |
| 146 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95251912 |
| 147 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.94882937 |
| 148 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94330667 |
| 149 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94136452 |
| 150 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94066318 |
| 151 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.93537097 |
| 152 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93369929 |
| 153 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92661838 |
| 154 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92259003 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90232905 |
| 156 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89978540 |
| 157 | AR_20517297_ChIP-Seq_VCAP_Human | 0.89970978 |
| 158 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89270127 |
| 159 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89157780 |
| 160 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.88211958 |
| 161 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.87540776 |
| 162 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87024534 |
| 163 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86511453 |
| 164 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.86018818 |
| 165 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85336410 |
| 166 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.85255441 |
| 167 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.85083744 |
| 168 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85074845 |
| 169 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84976613 |
| 170 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.84732150 |
| 171 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84111737 |
| 172 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.83928527 |
| 173 | AR_25329375_ChIP-Seq_VCAP_Human | 0.83868462 |
| 174 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.83827123 |
| 175 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.83018351 |
| 176 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.82830910 |
| 177 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82124052 |
| 178 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.80795637 |
| 179 | EWS_26573619_Chip-Seq_HEK293_Human | 0.80602173 |
| 180 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.79341635 |
| 181 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.79327010 |
| 182 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.78743791 |
| 183 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.78081286 |
| 184 | GATA1_22025678_ChIP-Seq_K562_Human | 0.77698942 |
| 185 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76281189 |
| 186 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76254268 |
| 187 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.75856765 |
| 188 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75368808 |
| 189 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75351232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 5.26198129 |
| 2 | MP0005171_absent_coat_pigmentation | 3.46849845 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 3.38473562 |
| 4 | MP0006054_spinal_hemorrhage | 3.09789279 |
| 5 | MP0005084_abnormal_gallbladder_morpholo | 3.05621342 |
| 6 | MP0000685_abnormal_immune_system | 2.91014857 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.78871186 |
| 8 | MP0000372_irregular_coat_pigmentation | 2.71997832 |
| 9 | MP0008058_abnormal_DNA_repair | 2.65699019 |
| 10 | MP0001800_abnormal_humoral_immune | 2.43017932 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.40925587 |
| 12 | MP0005174_abnormal_tail_pigmentation | 2.33678398 |
| 13 | MP0002822_catalepsy | 2.33531292 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.32489391 |
| 15 | MP0008877_abnormal_DNA_methylation | 2.28418937 |
| 16 | MP0001529_abnormal_vocalization | 2.27095478 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.26278115 |
| 18 | MP0005671_abnormal_response_to | 2.24293050 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 2.21075632 |
| 20 | MP0008961_abnormal_basal_metabolism | 2.17232229 |
| 21 | MP0004808_abnormal_hematopoietic_stem | 2.13362851 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.10801659 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.10066663 |
| 24 | MP0003690_abnormal_glial_cell | 2.07513287 |
| 25 | MP0002398_abnormal_bone_marrow | 2.04729677 |
| 26 | MP0008789_abnormal_olfactory_epithelium | 2.04225337 |
| 27 | MP0005551_abnormal_eye_electrophysiolog | 2.00773619 |
| 28 | MP0003763_abnormal_thymus_physiology | 2.00486637 |
| 29 | MP0003279_aneurysm | 1.99807211 |
| 30 | MP0003880_abnormal_central_pattern | 1.96120163 |
| 31 | MP0002102_abnormal_ear_morphology | 1.94309367 |
| 32 | MP0003718_maternal_effect | 1.92293978 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.92236978 |
| 34 | MP0003646_muscle_fatigue | 1.91639032 |
| 35 | MP0000465_gastrointestinal_hemorrhage | 1.90632161 |
| 36 | MP0003195_calcinosis | 1.85298569 |
| 37 | MP0002723_abnormal_immune_serum | 1.81405661 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.79578899 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.78031728 |
| 40 | MP0001873_stomach_inflammation | 1.76780431 |
| 41 | MP0002095_abnormal_skin_pigmentation | 1.75160242 |
| 42 | MP0002876_abnormal_thyroid_physiology | 1.74771975 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.74086471 |
| 44 | MP0001502_abnormal_circadian_rhythm | 1.71492055 |
| 45 | MP0001819_abnormal_immune_cell | 1.71271096 |
| 46 | MP0003303_peritoneal_inflammation | 1.69816947 |
| 47 | MP0003186_abnormal_redox_activity | 1.69094832 |
| 48 | MP0000716_abnormal_immune_system | 1.66184851 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.64200139 |
| 50 | MP0005387_immune_system_phenotype | 1.63572349 |
| 51 | MP0001790_abnormal_immune_system | 1.63572349 |
| 52 | MP0004147_increased_porphyrin_level | 1.62119434 |
| 53 | MP0004859_abnormal_synaptic_plasticity | 1.61826546 |
| 54 | MP0005253_abnormal_eye_physiology | 1.60964447 |
| 55 | MP0005025_abnormal_response_to | 1.58847276 |
| 56 | MP0002722_abnormal_immune_system | 1.57009279 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.56985416 |
| 58 | MP0003011_delayed_dark_adaptation | 1.56079632 |
| 59 | MP0002736_abnormal_nociception_after | 1.54637549 |
| 60 | MP0005394_taste/olfaction_phenotype | 1.54378098 |
| 61 | MP0005499_abnormal_olfactory_system | 1.54378098 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.51611626 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.51453012 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.51372257 |
| 65 | MP0001984_abnormal_olfaction | 1.51354306 |
| 66 | MP0001905_abnormal_dopamine_level | 1.49954447 |
| 67 | MP0001986_abnormal_taste_sensitivity | 1.49236380 |
| 68 | MP0006276_abnormal_autonomic_nervous | 1.46525121 |
| 69 | MP0002419_abnormal_innate_immunity | 1.46166927 |
| 70 | MP0004233_abnormal_muscle_weight | 1.46098837 |
| 71 | MP0002638_abnormal_pupillary_reflex | 1.45848660 |
| 72 | MP0003693_abnormal_embryo_hatching | 1.45519917 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 1.44442391 |
| 74 | MP0003786_premature_aging | 1.43795425 |
| 75 | MP0002429_abnormal_blood_cell | 1.42380795 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 1.41464799 |
| 77 | MP0002166_altered_tumor_susceptibility | 1.41162623 |
| 78 | MP0008569_lethality_at_weaning | 1.40666386 |
| 79 | MP0005000_abnormal_immune_tolerance | 1.40232397 |
| 80 | MP0002751_abnormal_autonomic_nervous | 1.39689474 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 1.38608408 |
| 82 | MP0001727_abnormal_embryo_implantation | 1.36820863 |
| 83 | MP0006035_abnormal_mitochondrial_morpho | 1.33074011 |
| 84 | MP0009697_abnormal_copulation | 1.32997053 |
| 85 | MP0003252_abnormal_bile_duct | 1.32441729 |
| 86 | MP0004130_abnormal_muscle_cell | 1.31765811 |
| 87 | MP0010234_abnormal_vibrissa_follicle | 1.30427261 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 1.29571779 |
| 89 | MP0001545_abnormal_hematopoietic_system | 1.29571779 |
| 90 | MP0008007_abnormal_cellular_replicative | 1.27539464 |
| 91 | MP0008932_abnormal_embryonic_tissue | 1.27459390 |
| 92 | MP0004133_heterotaxia | 1.26119824 |
| 93 | MP0005646_abnormal_pituitary_gland | 1.26047151 |
| 94 | MP0000015_abnormal_ear_pigmentation | 1.25300324 |
| 95 | MP0008775_abnormal_heart_ventricle | 1.24079707 |
| 96 | MP0005408_hypopigmentation | 1.22922942 |
| 97 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21701608 |
| 98 | MP0001851_eye_inflammation | 1.20831007 |
| 99 | MP0001853_heart_inflammation | 1.19845669 |
| 100 | MP0008995_early_reproductive_senescence | 1.19584927 |
| 101 | MP0003950_abnormal_plasma_membrane | 1.19344716 |
| 102 | MP0003111_abnormal_nucleus_morphology | 1.19005518 |
| 103 | MP0005076_abnormal_cell_differentiation | 1.18216953 |
| 104 | MP0008872_abnormal_physiological_respon | 1.15989330 |
| 105 | MP0003077_abnormal_cell_cycle | 1.15271031 |
| 106 | MP0004947_skin_inflammation | 1.14781553 |
| 107 | MP0009046_muscle_twitch | 1.12344887 |
| 108 | * MP0001915_intracranial_hemorrhage | 1.11238665 |
| 109 | MP0002938_white_spotting | 1.10458357 |
| 110 | MP0001968_abnormal_touch/_nociception | 1.09465830 |
| 111 | MP0002405_respiratory_system_inflammati | 1.09455549 |
| 112 | MP0002272_abnormal_nervous_system | 1.08434758 |
| 113 | MP0003632_abnormal_nervous_system | 1.07021580 |
| 114 | MP0002160_abnormal_reproductive_system | 1.06877326 |
| 115 | MP0000858_altered_metastatic_potential | 1.06191012 |
| 116 | MP0002006_tumorigenesis | 1.04338941 |
| 117 | MP0009745_abnormal_behavioral_response | 1.02143535 |
| 118 | MP0000631_abnormal_neuroendocrine_gland | 1.01999800 |
| 119 | MP0000490_abnormal_crypts_of | 1.00905735 |
| 120 | MP0010094_abnormal_chromosome_stability | 1.00893150 |
| 121 | MP0009278_abnormal_bone_marrow | 1.00701573 |
| 122 | MP0002928_abnormal_bile_duct | 0.99842049 |
| 123 | MP0003091_abnormal_cell_migration | 0.99771401 |
| 124 | MP0005220_abnormal_exocrine_pancreas | 0.99729838 |
| 125 | MP0009840_abnormal_foam_cell | 0.99465812 |
| 126 | MP0000358_abnormal_cell_content/ | 0.99081074 |
| 127 | MP0002735_abnormal_chemical_nociception | 0.97199202 |
| 128 | MP0003890_abnormal_embryonic-extraembry | 0.97035215 |
| 129 | MP0002210_abnormal_sex_determination | 0.96613021 |
| 130 | MP0009785_altered_susceptibility_to | 0.96591969 |
| 131 | MP0004215_abnormal_myocardial_fiber | 0.96354749 |
| 132 | MP0001270_distended_abdomen | 0.96266581 |
| 133 | MP0010386_abnormal_urinary_bladder | 0.95603735 |
| 134 | MP0000920_abnormal_myelination | 0.95358971 |
| 135 | MP0006082_CNS_inflammation | 0.94525771 |
| 136 | * MP0003121_genomic_imprinting | 0.92814168 |
| 137 | MP0002572_abnormal_emotion/affect_behav | 0.90846360 |
| 138 | MP0003633_abnormal_nervous_system | 0.89531064 |
| 139 | MP0001293_anophthalmia | 0.89506939 |
| 140 | MP0001929_abnormal_gametogenesis | 0.89117833 |
| 141 | MP0000516_abnormal_urinary_system | 0.88655252 |
| 142 | MP0005367_renal/urinary_system_phenotyp | 0.88655252 |
| 143 | MP0009384_cardiac_valve_regurgitation | 0.88436478 |
| 144 | MP0005195_abnormal_posterior_eye | 0.87106182 |
| 145 | MP0005379_endocrine/exocrine_gland_phen | 0.86948190 |
| 146 | MP0002234_abnormal_pharynx_morphology | 0.86269158 |
| 147 | MP0003045_fibrosis | 0.85893389 |
| 148 | MP0002138_abnormal_hepatobiliary_system | 0.85629957 |
| 149 | MP0002557_abnormal_social/conspecific_i | 0.85103905 |
| 150 | MP0001324_abnormal_eye_pigmentation | 0.85081965 |
| 151 | MP0005621_abnormal_cell_physiology | 0.84924608 |
| 152 | MP0002089_abnormal_postnatal_growth/wei | 0.84840852 |
| 153 | MP0010155_abnormal_intestine_physiology | 0.83261048 |
| 154 | MP0002019_abnormal_tumor_incidence | 0.82104828 |
| 155 | MP0000653_abnormal_sex_gland | 0.81618578 |
| 156 | MP0001764_abnormal_homeostasis | 0.81243817 |
| 157 | MP0005389_reproductive_system_phenotype | 0.81068155 |
| 158 | MP0000427_abnormal_hair_cycle | 0.80550049 |
| 159 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79921194 |
| 160 | MP0003631_nervous_system_phenotype | 0.79466781 |
| 161 | MP0002653_abnormal_ependyma_morphology | 0.78917496 |
| 162 | MP0010307_abnormal_tumor_latency | 0.78626237 |
| 163 | MP0004510_myositis | 0.78533215 |
| 164 | MP0000604_amyloidosis | 0.78297190 |
| 165 | MP0001145_abnormal_male_reproductive | 0.78029718 |
| 166 | MP0001845_abnormal_inflammatory_respons | 0.77855247 |
| 167 | MP0005332_abnormal_amino_acid | 0.77706791 |
| 168 | MP0003866_abnormal_defecation | 0.76912270 |
| 169 | MP0004142_abnormal_muscle_tone | 0.76303526 |
| 170 | MP0000350_abnormal_cell_proliferation | 0.76166634 |
| 171 | MP0003634_abnormal_glial_cell | 0.76031012 |
| 172 | MP0003943_abnormal_hepatobiliary_system | 0.73709915 |
| 173 | MP0004858_abnormal_nervous_system | 0.73556648 |
| 174 | MP0004957_abnormal_blastocyst_morpholog | 0.73406751 |
| 175 | MP0002752_abnormal_somatic_nervous | 0.73012456 |
| 176 | MP0000778_abnormal_nervous_system | 0.72256995 |
| 177 | MP0005395_other_phenotype | 0.71801318 |
| 178 | MP0001849_ear_inflammation | 0.69456708 |
| 179 | MP0003436_decreased_susceptibility_to | 0.69148737 |
| 180 | MP0004811_abnormal_neuron_physiology | 0.67031513 |
| 181 | MP0002075_abnormal_coat/hair_pigmentati | 0.64981111 |
| 182 | MP0001661_extended_life_span | 0.64860412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.35918234 |
| 2 | Hypoplasia of the thymus (HP:0000778) | 4.03042231 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.02431781 |
| 4 | Acute encephalopathy (HP:0006846) | 4.01878306 |
| 5 | Increased CSF lactate (HP:0002490) | 3.93808538 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.92737747 |
| 7 | Agammaglobulinemia (HP:0004432) | 3.84805370 |
| 8 | Abnormality of macular pigmentation (HP:0008002) | 3.81219335 |
| 9 | Progressive macrocephaly (HP:0004481) | 3.69345438 |
| 10 | Hepatocellular necrosis (HP:0001404) | 3.67175749 |
| 11 | B lymphocytopenia (HP:0010976) | 3.58578668 |
| 12 | Abnormality of B cell number (HP:0010975) | 3.58578668 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.57000513 |
| 14 | Thyroiditis (HP:0100646) | 3.43283699 |
| 15 | Hepatic necrosis (HP:0002605) | 3.42939511 |
| 16 | Spondylolisthesis (HP:0003302) | 3.42277315 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.35182631 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.33805894 |
| 19 | Cellulitis (HP:0100658) | 3.29726103 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.26334043 |
| 21 | Lipid accumulation in hepatocytes (HP:0006561) | 3.26326513 |
| 22 | Severe combined immunodeficiency (HP:0004430) | 3.22754355 |
| 23 | Renal Fanconi syndrome (HP:0001994) | 3.21912644 |
| 24 | Abnormality of the fingertips (HP:0001211) | 3.19631474 |
| 25 | Recurrent viral infections (HP:0004429) | 3.18706796 |
| 26 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.18128116 |
| 27 | Molar tooth sign on MRI (HP:0002419) | 3.08689345 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 3.08689345 |
| 29 | IgM deficiency (HP:0002850) | 3.07071682 |
| 30 | Cerebral edema (HP:0002181) | 3.02983701 |
| 31 | Constricted visual fields (HP:0001133) | 3.01839055 |
| 32 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.01083488 |
| 33 | Methylmalonic acidemia (HP:0002912) | 3.00902167 |
| 34 | Pancreatic cysts (HP:0001737) | 2.96007076 |
| 35 | Abnormal auditory evoked potentials (HP:0006958) | 2.94209269 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 2.94010800 |
| 37 | Recurrent fungal infections (HP:0002841) | 2.91967472 |
| 38 | Large for gestational age (HP:0001520) | 2.90436753 |
| 39 | Optic disc pallor (HP:0000543) | 2.90210330 |
| 40 | Diplopia (HP:0000651) | 2.89929343 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.89929343 |
| 42 | Recurrent bronchitis (HP:0002837) | 2.82219876 |
| 43 | Verrucae (HP:0200043) | 2.81475388 |
| 44 | Papilloma (HP:0012740) | 2.81475388 |
| 45 | Medial flaring of the eyebrow (HP:0010747) | 2.79062935 |
| 46 | Nephronophthisis (HP:0000090) | 2.78813747 |
| 47 | Combined immunodeficiency (HP:0005387) | 2.75882632 |
| 48 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.75393780 |
| 49 | Recurrent cutaneous fungal infections (HP:0011370) | 2.75393780 |
| 50 | White forelock (HP:0002211) | 2.75185541 |
| 51 | Hemiplegia (HP:0002301) | 2.71385489 |
| 52 | Broad face (HP:0000283) | 2.71234831 |
| 53 | Clumsiness (HP:0002312) | 2.70379903 |
| 54 | Lactic acidosis (HP:0003128) | 2.70084017 |
| 55 | T lymphocytopenia (HP:0005403) | 2.69745923 |
| 56 | Pancreatic fibrosis (HP:0100732) | 2.68654358 |
| 57 | IgG deficiency (HP:0004315) | 2.65465960 |
| 58 | Attenuation of retinal blood vessels (HP:0007843) | 2.64904284 |
| 59 | True hermaphroditism (HP:0010459) | 2.64626076 |
| 60 | Abnormality of renal resorption (HP:0011038) | 2.60354926 |
| 61 | Abnormality of the labia minora (HP:0012880) | 2.60180877 |
| 62 | Methylmalonic aciduria (HP:0012120) | 2.58328050 |
| 63 | Arterial tortuosity (HP:0005116) | 2.56953807 |
| 64 | Increased serum lactate (HP:0002151) | 2.53963414 |
| 65 | Abnormality of T cell number (HP:0011839) | 2.53084173 |
| 66 | Asplenia (HP:0001746) | 2.50959654 |
| 67 | Patchy hypopigmentation of hair (HP:0011365) | 2.50543071 |
| 68 | Sepsis (HP:0100806) | 2.50277850 |
| 69 | Hypothermia (HP:0002045) | 2.45673631 |
| 70 | Gastrointestinal stroma tumor (HP:0100723) | 2.45614328 |
| 71 | Hyperacusis (HP:0010780) | 2.45460857 |
| 72 | Myositis (HP:0100614) | 2.45412937 |
| 73 | Abolished electroretinogram (ERG) (HP:0000550) | 2.45317723 |
| 74 | Abnormal biliary tract physiology (HP:0012439) | 2.44799483 |
| 75 | Bile duct proliferation (HP:0001408) | 2.44799483 |
| 76 | Nasal polyposis (HP:0100582) | 2.44031070 |
| 77 | Congenital stationary night blindness (HP:0007642) | 2.42663230 |
| 78 | Renal cortical cysts (HP:0000803) | 2.40285455 |
| 79 | Respiratory failure (HP:0002878) | 2.38964331 |
| 80 | Exertional dyspnea (HP:0002875) | 2.34564990 |
| 81 | Abnormality of the renal medulla (HP:0100957) | 2.32983965 |
| 82 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32829721 |
| 83 | Meningitis (HP:0001287) | 2.28548081 |
| 84 | Tubulointerstitial nephritis (HP:0001970) | 2.28468187 |
| 85 | Albinism (HP:0001022) | 2.28433694 |
| 86 | Abnormality of the renal cortex (HP:0011035) | 2.27995002 |
| 87 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.27515230 |
| 88 | Adrenal hypoplasia (HP:0000835) | 2.24340687 |
| 89 | Abnormality of urine glucose concentration (HP:0011016) | 2.23000477 |
| 90 | Glycosuria (HP:0003076) | 2.23000477 |
| 91 | Megalencephaly (HP:0001355) | 2.22689313 |
| 92 | Type II lissencephaly (HP:0007260) | 2.22528080 |
| 93 | Congenital primary aphakia (HP:0007707) | 2.22099518 |
| 94 | Osteomyelitis (HP:0002754) | 2.21448454 |
| 95 | * Increased nuchal translucency (HP:0010880) | 2.19828826 |
| 96 | Chronic otitis media (HP:0000389) | 2.19138102 |
| 97 | Gait imbalance (HP:0002141) | 2.18883666 |
| 98 | Spastic diplegia (HP:0001264) | 2.18678008 |
| 99 | Nephrogenic diabetes insipidus (HP:0009806) | 2.18051888 |
| 100 | Generalized aminoaciduria (HP:0002909) | 2.16237655 |
| 101 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.16174825 |
| 102 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.16174825 |
| 103 | Aplastic anemia (HP:0001915) | 2.15046984 |
| 104 | Lymphopenia (HP:0001888) | 2.14868056 |
| 105 | Vascular tortuosity (HP:0004948) | 2.14381765 |
| 106 | Pendular nystagmus (HP:0012043) | 2.13572817 |
| 107 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.11671895 |
| 108 | Recurrent skin infections (HP:0001581) | 2.10933728 |
| 109 | Paraparesis (HP:0002385) | 2.10381132 |
| 110 | Exercise intolerance (HP:0003546) | 2.10194269 |
| 111 | Hyperglycinemia (HP:0002154) | 2.09474274 |
| 112 | Increased serum pyruvate (HP:0003542) | 2.09417868 |
| 113 | Abnormality of eosinophils (HP:0001879) | 2.09385988 |
| 114 | Spastic paraparesis (HP:0002313) | 2.08805891 |
| 115 | Subacute progressive viral hepatitis (HP:0006572) | 2.07543745 |
| 116 | Sclerocornea (HP:0000647) | 2.06923662 |
| 117 | Lissencephaly (HP:0001339) | 2.05742821 |
| 118 | Abnormality of the columella (HP:0009929) | 2.05097116 |
| 119 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.03561165 |
| 120 | Depressed nasal tip (HP:0000437) | 2.02169885 |
| 121 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.01061766 |
| 122 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.99088997 |
| 123 | Entropion (HP:0000621) | 1.97932285 |
| 124 | Congenital, generalized hypertrichosis (HP:0004540) | 1.97654986 |
| 125 | Eosinophilia (HP:0001880) | 1.97464657 |
| 126 | Delayed CNS myelination (HP:0002188) | 1.96167304 |
| 127 | Cone-rod dystrophy (HP:0000548) | 1.95950888 |
| 128 | Epiphyseal stippling (HP:0010655) | 1.93671535 |
| 129 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.93491607 |
| 130 | * Synophrys (HP:0000664) | 1.93254808 |
| 131 | Abnormality of glycolysis (HP:0004366) | 1.92341392 |
| 132 | Postaxial foot polydactyly (HP:0001830) | 1.91947618 |
| 133 | CNS demyelination (HP:0007305) | 1.90524562 |
| 134 | Lethargy (HP:0001254) | 1.89805778 |
| 135 | Slow-growing hair (HP:0002217) | 1.88816190 |
| 136 | Abnormality of hair growth rate (HP:0011363) | 1.88816190 |
| 137 | Recurrent bacterial skin infections (HP:0005406) | 1.88382874 |
| 138 | Chronic sinusitis (HP:0011109) | 1.88155939 |
| 139 | Mitral regurgitation (HP:0001653) | 1.88122265 |
| 140 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.87378842 |
| 141 | Recurrent sinusitis (HP:0011108) | 1.86166988 |
| 142 | Aqueductal stenosis (HP:0002410) | 1.86133354 |
| 143 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.85847399 |
| 144 | Limb dystonia (HP:0002451) | 1.85085789 |
| 145 | Abnormality of T cells (HP:0002843) | 1.84346875 |
| 146 | Short tibia (HP:0005736) | 1.83842261 |
| 147 | Abnormality of the nasal mucosa (HP:0000433) | 1.83556599 |
| 148 | Severe muscular hypotonia (HP:0006829) | 1.83389012 |
| 149 | Cerebellar dysplasia (HP:0007033) | 1.82952889 |
| 150 | Neuronal loss in central nervous system (HP:0002529) | 1.82742179 |
| 151 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.82686316 |
| 152 | Degeneration of anterior horn cells (HP:0002398) | 1.82504131 |
| 153 | Abnormality of the anterior horn cell (HP:0006802) | 1.82504131 |
| 154 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.80173743 |
| 155 | Abnormality of vitamin B metabolism (HP:0004340) | 1.78627321 |
| 156 | Chronic hepatic failure (HP:0100626) | 1.77698541 |
| 157 | Brushfield spots (HP:0001088) | 1.77072695 |
| 158 | Recurrent abscess formation (HP:0002722) | 1.76930797 |
| 159 | Type I transferrin isoform profile (HP:0003642) | 1.76899946 |
| 160 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.76827948 |
| 161 | Trigonocephaly (HP:0000243) | 1.76181386 |
| 162 | Autoimmune thrombocytopenia (HP:0001973) | 1.75884633 |
| 163 | Narrow nasal bridge (HP:0000446) | 1.75864420 |
| 164 | Retinitis pigmentosa (HP:0000510) | 1.75227928 |
| 165 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.75213868 |
| 166 | Heterochromia iridis (HP:0001100) | 1.75188119 |
| 167 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74618387 |
| 168 | Abnormality of the intervertebral disk (HP:0005108) | 1.74446269 |
| 169 | Hyperphosphaturia (HP:0003109) | 1.73777634 |
| 170 | Oligodactyly (HP:0012165) | 1.72451690 |
| 171 | Male pseudohermaphroditism (HP:0000037) | 1.71977354 |
| 172 | Hypoplasia of the fovea (HP:0007750) | 1.71812627 |
| 173 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.71812627 |
| 174 | Hypoproteinemia (HP:0003075) | 1.71674908 |
| 175 | Mutism (HP:0002300) | 1.71530058 |
| 176 | Epileptic encephalopathy (HP:0200134) | 1.71478163 |
| 177 | Prolonged bleeding time (HP:0003010) | 1.70149247 |
| 178 | Acute lymphatic leukemia (HP:0006721) | 1.70119946 |
| 179 | Genital tract atresia (HP:0001827) | 1.69867838 |
| 180 | Increased muscle lipid content (HP:0009058) | 1.68619262 |
| 181 | Hepatitis (HP:0012115) | 1.68192343 |
| 182 | Protrusio acetabuli (HP:0003179) | 1.67964468 |
| 183 | Ragged-red muscle fibers (HP:0003200) | 1.67667343 |
| 184 | * X-linked dominant inheritance (HP:0001423) | 1.66936795 |
| 185 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.66849128 |
| 186 | Abnormality of alanine metabolism (HP:0010916) | 1.66849128 |
| 187 | Hyperalaninemia (HP:0003348) | 1.66849128 |
| 188 | Vaginal atresia (HP:0000148) | 1.66546206 |
| 189 | Generalized myoclonic seizures (HP:0002123) | 1.65605415 |
| 190 | Retinal dysplasia (HP:0007973) | 1.65089700 |
| 191 | Premature skin wrinkling (HP:0100678) | 1.64174536 |
| 192 | Severe visual impairment (HP:0001141) | 1.63461888 |
| 193 | Pachygyria (HP:0001302) | 1.63123277 |
| 194 | Leukocytosis (HP:0001974) | 1.62878095 |
| 195 | Skin rash (HP:0000988) | 1.62856268 |
| 196 | Abnormal drinking behavior (HP:0030082) | 1.62842014 |
| 197 | Polydipsia (HP:0001959) | 1.62842014 |
| 198 | Increased density of long bones (HP:0006392) | 1.61235839 |
| 199 | Viral hepatitis (HP:0006562) | 1.58948418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.53976141 |
| 2 | KIT | 3.31442579 |
| 3 | EEF2K | 3.07883121 |
| 4 | TNIK | 3.02741643 |
| 5 | MAP4K2 | 2.98554497 |
| 6 | MAP3K10 | 2.85457435 |
| 7 | FRK | 2.76438079 |
| 8 | NEK1 | 2.64402777 |
| 9 | WNK3 | 2.62425795 |
| 10 | BCKDK | 2.52761068 |
| 11 | VRK2 | 2.50221373 |
| 12 | BMPR1B | 2.27863441 |
| 13 | TRIM28 | 2.27635787 |
| 14 | CSF1R | 2.26604887 |
| 15 | FGFR4 | 2.21943450 |
| 16 | NTRK2 | 2.18880393 |
| 17 | TXK | 2.17501926 |
| 18 | JAK3 | 2.08876771 |
| 19 | NUAK1 | 2.04282964 |
| 20 | STK10 | 2.01665097 |
| 21 | ERBB3 | 2.00765734 |
| 22 | ZAK | 1.99527451 |
| 23 | SIK1 | 1.96060848 |
| 24 | PLK2 | 1.93089993 |
| 25 | TYK2 | 1.85516301 |
| 26 | EIF2AK1 | 1.79478399 |
| 27 | FLT3 | 1.79170468 |
| 28 | TRIB3 | 1.77809287 |
| 29 | BCR | 1.73321250 |
| 30 | DMPK | 1.72431059 |
| 31 | MAPK11 | 1.71732877 |
| 32 | PLK3 | 1.71146096 |
| 33 | MAP3K12 | 1.70417081 |
| 34 | PTK6 | 1.67982621 |
| 35 | BMPR2 | 1.65982952 |
| 36 | CDK8 | 1.60907906 |
| 37 | MAP3K7 | 1.60468817 |
| 38 | ERN1 | 1.56856837 |
| 39 | PLK4 | 1.53033062 |
| 40 | FGFR3 | 1.46912456 |
| 41 | GRK1 | 1.43292276 |
| 42 | LRRK2 | 1.43263034 |
| 43 | PRKCH | 1.40227902 |
| 44 | MAP3K6 | 1.40166101 |
| 45 | LIMK1 | 1.38629970 |
| 46 | MARK2 | 1.36862809 |
| 47 | PBK | 1.36791769 |
| 48 | GRK6 | 1.36476796 |
| 49 | IKBKE | 1.35249024 |
| 50 | PAK4 | 1.31329192 |
| 51 | JAK1 | 1.30648137 |
| 52 | ITK | 1.28498048 |
| 53 | STK38L | 1.27596198 |
| 54 | ZAP70 | 1.25501613 |
| 55 | MAP3K4 | 1.23819076 |
| 56 | MAP2K7 | 1.20919878 |
| 57 | TEC | 1.19924640 |
| 58 | STK39 | 1.18501221 |
| 59 | ADRBK2 | 1.13841168 |
| 60 | BTK | 1.13796846 |
| 61 | CCNB1 | 1.13340785 |
| 62 | TSSK6 | 1.10944657 |
| 63 | OXSR1 | 1.10764309 |
| 64 | PINK1 | 1.10696827 |
| 65 | TESK2 | 1.09353567 |
| 66 | MAPK13 | 1.07607551 |
| 67 | PDK2 | 1.06712777 |
| 68 | TIE1 | 1.05061549 |
| 69 | STK16 | 1.04600368 |
| 70 | NME1 | 1.04283733 |
| 71 | SGK3 | 1.02952572 |
| 72 | MAPK7 | 1.02542269 |
| 73 | DYRK2 | 1.02190143 |
| 74 | TTK | 1.00980336 |
| 75 | CDK9 | 1.00493942 |
| 76 | FES | 1.00184875 |
| 77 | TBK1 | 0.97366052 |
| 78 | NEK2 | 0.96589597 |
| 79 | FER | 0.95277321 |
| 80 | MARK1 | 0.94135700 |
| 81 | MKNK2 | 0.93670676 |
| 82 | PLK1 | 0.92750339 |
| 83 | BUB1 | 0.92460057 |
| 84 | RIPK1 | 0.89995012 |
| 85 | LMTK2 | 0.88707206 |
| 86 | MKNK1 | 0.88586576 |
| 87 | PRKD2 | 0.87215833 |
| 88 | INSRR | 0.86546567 |
| 89 | BLK | 0.84693721 |
| 90 | CDK6 | 0.84598434 |
| 91 | MAPKAPK5 | 0.83771816 |
| 92 | PAK3 | 0.83476004 |
| 93 | SYK | 0.83326475 |
| 94 | LCK | 0.82956868 |
| 95 | MINK1 | 0.82657317 |
| 96 | PRKCI | 0.82295926 |
| 97 | WNK4 | 0.81606863 |
| 98 | PRKCE | 0.81127117 |
| 99 | ACVR1B | 0.78476273 |
| 100 | MAP3K13 | 0.77480755 |
| 101 | CSNK1G3 | 0.77389132 |
| 102 | BRSK2 | 0.76523664 |
| 103 | TLK1 | 0.74627138 |
| 104 | CASK | 0.73193371 |
| 105 | ALK | 0.72743568 |
| 106 | MARK3 | 0.72443746 |
| 107 | RPS6KB2 | 0.71711065 |
| 108 | PRKD3 | 0.71240392 |
| 109 | SCYL2 | 0.69837511 |
| 110 | DAPK1 | 0.68714244 |
| 111 | CDK4 | 0.68670254 |
| 112 | MAP2K4 | 0.68105908 |
| 113 | PRKCG | 0.68096237 |
| 114 | SGK2 | 0.67169602 |
| 115 | CSNK1G2 | 0.66714754 |
| 116 | HCK | 0.66607734 |
| 117 | PRKD1 | 0.66510085 |
| 118 | ATR | 0.65057563 |
| 119 | ATM | 0.64067336 |
| 120 | TAF1 | 0.63108249 |
| 121 | PHKG2 | 0.62605769 |
| 122 | PHKG1 | 0.62605769 |
| 123 | EIF2AK2 | 0.62561564 |
| 124 | CSNK1A1L | 0.62257642 |
| 125 | MAP2K3 | 0.61541081 |
| 126 | EIF2AK3 | 0.60119966 |
| 127 | SIK2 | 0.59990702 |
| 128 | HIPK2 | 0.57581546 |
| 129 | CDC7 | 0.56189254 |
| 130 | RPS6KA4 | 0.54595842 |
| 131 | CDK19 | 0.54230875 |
| 132 | PIM2 | 0.52888946 |
| 133 | PAK6 | 0.52456263 |
| 134 | ADRBK1 | 0.51440212 |
| 135 | CAMKK2 | 0.50762693 |
| 136 | CSNK1G1 | 0.48093269 |
| 137 | STK3 | 0.47378856 |
| 138 | JAK2 | 0.46932335 |
| 139 | MUSK | 0.46318859 |
| 140 | CLK1 | 0.46043577 |
| 141 | RPS6KA5 | 0.45836031 |
| 142 | CAMK2A | 0.45605178 |
| 143 | WEE1 | 0.45324315 |
| 144 | ILK | 0.44745406 |
| 145 | MST4 | 0.43904965 |
| 146 | CSNK1A1 | 0.43710039 |
| 147 | PRKACB | 0.43261863 |
| 148 | AURKB | 0.43258287 |
| 149 | PIK3CA | 0.42745796 |
| 150 | IKBKB | 0.42377810 |
| 151 | AKT2 | 0.42189638 |
| 152 | CHEK2 | 0.42041985 |
| 153 | CSNK1D | 0.41322157 |
| 154 | CSNK2A1 | 0.40847187 |
| 155 | PRKCQ | 0.40542290 |
| 156 | SIK3 | 0.40112712 |
| 157 | CDK3 | 0.39469251 |
| 158 | ERBB2 | 0.37833493 |
| 159 | ROCK2 | 0.37730448 |
| 160 | VRK1 | 0.37690746 |
| 161 | GRK7 | 0.37638196 |
| 162 | * PRKACA | 0.37491428 |
| 163 | MTOR | 0.37466281 |
| 164 | LYN | 0.37321047 |
| 165 | IGF1R | 0.37033102 |
| 166 | MAP3K8 | 0.36528264 |
| 167 | TESK1 | 0.36523561 |
| 168 | CAMK1G | 0.35684468 |
| 169 | MAPK9 | 0.34535481 |
| 170 | MAPK12 | 0.32990438 |
| 171 | MAP3K11 | 0.32615210 |
| 172 | FYN | 0.32586186 |
| 173 | MAPK3 | 0.31560881 |
| 174 | PIM1 | 0.30510476 |
| 175 | MAP3K5 | 0.29749534 |
| 176 | SRPK1 | 0.29628580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.96139220 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.89102140 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.75851256 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.25958545 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.13838296 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.86523004 |
| 7 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.83630106 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.45521644 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.34740202 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.27864922 |
| 11 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.25477902 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25203588 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.22925102 |
| 14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.20754246 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 2.16064930 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 2.03658062 |
| 17 | Alzheimers disease_Homo sapiens_hsa05010 | 1.98947403 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.95095218 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92756294 |
| 20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.90026158 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82835273 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.80078614 |
| 23 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.79178470 |
| 24 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.68824644 |
| 25 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.66964425 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.63607083 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.58925017 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57359810 |
| 29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.56034023 |
| 30 | RNA degradation_Homo sapiens_hsa03018 | 1.55593744 |
| 31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.52113140 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.52067727 |
| 33 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.50965301 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.50154910 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49012657 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47075986 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.46236223 |
| 38 | Colorectal cancer_Homo sapiens_hsa05210 | 1.45359799 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43958815 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.40709478 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.39384812 |
| 42 | Peroxisome_Homo sapiens_hsa04146 | 1.38753281 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.37660248 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.37529195 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36767376 |
| 46 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33740006 |
| 47 | Leishmaniasis_Homo sapiens_hsa05140 | 1.33345700 |
| 48 | Circadian rhythm_Homo sapiens_hsa04710 | 1.32113274 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31250691 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29610253 |
| 51 | Ribosome_Homo sapiens_hsa03010 | 1.27507642 |
| 52 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.23757708 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23700891 |
| 54 | DNA replication_Homo sapiens_hsa03030 | 1.23408264 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 1.23074007 |
| 56 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 1.22876905 |
| 57 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22731429 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 1.21754348 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21554674 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20425967 |
| 61 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.19312711 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.19004259 |
| 63 | Cell cycle_Homo sapiens_hsa04110 | 1.17799755 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16963751 |
| 65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.16643172 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 1.16629553 |
| 67 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13702676 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12134903 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.12024780 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.11332705 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08743426 |
| 72 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08071101 |
| 73 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.06512730 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06491365 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06184347 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 1.03458588 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.02673245 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 1.02301951 |
| 79 | Nicotine addiction_Homo sapiens_hsa05033 | 1.00652298 |
| 80 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00426699 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00071572 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.98918110 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98829214 |
| 84 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.98755659 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.98016315 |
| 86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97543216 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.97506917 |
| 88 | RNA transport_Homo sapiens_hsa03013 | 0.97449825 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.97180199 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.96666555 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95874414 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94353639 |
| 93 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.92703836 |
| 94 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90339818 |
| 95 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90306779 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.89920549 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.89002823 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.87450382 |
| 99 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86861049 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84028064 |
| 101 | Base excision repair_Homo sapiens_hsa03410 | 0.83272707 |
| 102 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82578425 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80365231 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80186161 |
| 105 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78834186 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78418983 |
| 107 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.76552244 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75612595 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.75531010 |
| 110 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74572171 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74208385 |
| 112 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.74162359 |
| 113 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72692762 |
| 114 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.72344543 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72309789 |
| 116 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.71547086 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70428478 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69652527 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.69351811 |
| 120 | * Alcoholism_Homo sapiens_hsa05034 | 0.69195114 |
| 121 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68152538 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68005629 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66624808 |
| 124 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66499430 |
| 125 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66007362 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65656036 |
| 127 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65626548 |
| 128 | Malaria_Homo sapiens_hsa05144 | 0.64914785 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64016434 |
| 130 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63492695 |
| 131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62757829 |
| 132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.62680485 |
| 133 | Taste transduction_Homo sapiens_hsa04742 | 0.61733712 |
| 134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61208667 |
| 135 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.60854746 |
| 136 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.60717650 |
| 137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59806614 |
| 138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59398146 |
| 139 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.59254272 |
| 140 | Lysosome_Homo sapiens_hsa04142 | 0.57897368 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57463344 |
| 142 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57420543 |
| 143 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57212651 |
| 144 | Spliceosome_Homo sapiens_hsa03040 | 0.57192738 |
| 145 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56945862 |
| 146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56378197 |
| 147 | Morphine addiction_Homo sapiens_hsa05032 | 0.56177226 |
| 148 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55071356 |
| 149 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54506716 |
| 150 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53305960 |
| 151 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53101460 |
| 152 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52693962 |
| 153 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52150482 |
| 154 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51522811 |
| 155 | Tuberculosis_Homo sapiens_hsa05152 | 0.50370218 |
| 156 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50239382 |
| 157 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50016857 |
| 158 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49584234 |
| 159 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49472017 |
| 160 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49332698 |
| 161 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48565937 |
| 162 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46370084 |
| 163 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.46089340 |
| 164 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45979281 |
| 165 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.44378519 |
| 166 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42531525 |
| 167 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40552582 |
| 168 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39400718 |
| 169 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39183392 |
| 170 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38292048 |
| 171 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37695219 |
| 172 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37371735 |
| 173 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37186034 |
| 174 | Insulin resistance_Homo sapiens_hsa04931 | 0.35600699 |
| 175 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.34752328 |
| 176 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34087661 |
| 177 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33626781 |
| 178 | Carbon metabolism_Homo sapiens_hsa01200 | 0.33439125 |
| 179 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33195502 |
| 180 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.32370608 |
| 181 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.32152668 |
| 182 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30918225 |

